• ATAI Announces Neuronasal Completes Pilot Study americanpharmaceuticalreview
    November 05, 2020
    ATAI Life Sciences announced Neuronasal has completed its pilot study intended to show nose to brain delivery of N-acetylcysteine (NAC) in healthy volunteers.
PharmaSources Customer Service